Pacific Biosciences of California Stock Discussion

$Pacific Biosciences of California (PACB.US)$
The publication in the American Journal of Human Genetics showcasing a 93% detection rate of pathogenic variants using PacBio's HiFi technology represents a pivotal advancement in rare disease diagnostics. The study's scale of 981 processed samples and commitment to 5,000 diagnostic genomes demonstrates significant commercial validation.
The operational improvements, particularly the automation enabling 24 samples per run wi...

$Pacific Biosciences of California (PACB.US)$
PacBio's HiFi Sequencing Achieves 93% Success Rate in Breakthrough Rare Disease Study

$Pacific Biosciences of California (PACB.US)$
Preliminary fourth quarter results:
• Preliminary, unaudited revenue for the fourth quarter of 2024 is expected to be approximately $39.2 million compared with $58.4 million in the prior-year period.
• Preliminary instrument revenue for the fourth quarter of 2024 is expected to be approximately $15.3 million, compared with $35.1 million for the fourth quarter of 2023. Preliminary instrument revenue in the fourth quarter of 2024 included 23 R...

$Pacific Biosciences of California (PACB.US)$ lets see if the newer highs react favorably to the previous order block at price level  and institutional buying push it up again

$Pacific Biosciences of California (PACB.US)$ When will this recover 😏

Its time to choose a side ？？
$Pacific Biosciences of California (PACB.US)$

$Pacific Biosciences of California (PACB.US)$ go on and climb dont be shy

$Pacific Biosciences of California (PACB.US)$ the fact that you have increased operating profit with such a crash in revenue suggesting that your leadership team is likely screwed. stop laying off people and focusing on creating market to sell your products.